redalpine — 2019 Investments
4 investments dated 2019 · listed companies and verified rows first · show all
b.next develops technologies and infrastructure for building synthetic cells from scratch, working with researchers, universities, governments, and funders.
BiotechDeep Tech
Akshay Maheshwari, MD, PhD(Founder)in
Co-investorsFifty YearsCometaConexo VenturesDN CapitalEnernFounders Future+2 more
Business Next (數位時代) is a Taiwanese digital news and media outlet covering technology, startups, AI, e-commerce, and business trends.
Media & Entertainment
Co-investorsAVA AngelsCometaConexo VenturesDN CapitalEnernFounders Future+2 more
Lengoo was a Berlin-based B2B startup offering AI-powered machine translation software that trained custom models on each enterprise client's own language data, combined with professional human linguists.
Berlin, DE
Co-investorsCreathor VenturesHOWZAT PartnersInkefPolipo VenturesRheingau FoundersTechstars+1 more
GENFIT is a biopharmaceutical company developing therapies for rare, life-threatening liver diseases, with a focus on acute-on-chronic liver failure (ACLF), hepatic encephalopathy (HE), cholangiocarcinoma, urea cycle disorders, and organic acidemias.
BiotechDigital HealthMedical Devices
Co-investorsOCCIDENTVerve VenturesEsperante VenturesHealthequity
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







.jpeg)